Streetbeat News

Stock Prices

CROX

Raymond James analyst Rick Patel upgraded Crocs Inc (NASDAQ:CROX) from Outperform to Strong Buy and increased the price target from $98 to $115. Patel forecasts a 10.3% revenue growth for FY23, aligning with the street view, and raised FY24 revenue growth estimates to 4% from 3%. The analyst expects HEYDUDE's growth to stabilize and return to growth in the second half of 2024. The stock's recent rise post-Q3 earnings suggests further upside, with Patel predicting a total revenue growth of 5.5-6% and an EPS of $12.65+ for FY24. CROX shares were up 4.51% at $100.50.

Portfolio Pulse from Shivani Kumaresan

November 28, 2023 | 5:31 pm

AUVIP

BGLC

CAPT

CBAT

CLIR

ESGL

HTOO

IPDN

PESI

SGLY

STCN

During Tuesday's intraday session, several industrial stocks experienced significant movements. Fusion Fuel Green (HTOO) saw a 35.2% increase, while Captivision (CAPT) dropped by 22.7%. Other notable gainers include ESGL Holdings (ESGL), Professional Diversity (IPDN), Steel Connect (STCN), and CBAK Energy Tech (CBAT). On the losing side, Singularity Future Tech (SGLY), Perma-Fix Environmental Services (PESI), Applied UV (AUVIP), ClearSign Technologies (CLIR), and BioNexus Gene Lab (BGLC) saw declines ranging from 12.85% to 16.02%.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 5:31 pm

CTRN

FUV

GME

PDD

PLBY

REE

VLCN

In Tuesday's intraday session, several consumer discretionary stocks experienced significant movements. Arcimoto, REE Automotive, PDD Holdings, PLBY Group, GameStop, and Yunji saw their stocks rise, with PDD Holdings releasing Q3 earnings. Conversely, Volcon, Harbor Custom Dev, Citi Trends, U Power, Connexa Sports Techs, and Esports Entertainment witnessed declines in their stock prices, with Citi Trends also releasing Q3 earnings.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 5:31 pm

HNRA

Shares of HNR Acquisition Corp. are trading higher following a business update from the company.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:31 pm

CABA

CDIO

HSCS

RDHL

SNES

THAR

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Redhill Biopharma (RDHL) saw a 62.0% increase, Cardio Diagnostics Hldgs (CDIO) rose by 27.87%, and Heart Test Laboratories (HSCS) increased by 24.98%. Conversely, Tharimmune (THAR) dropped by 71.8%, SenesTech (SNES) fell by 45.22%, and Cabaletta Bio (CABA) declined by 34.44%. Other notable movers included SpringWorks Therapeutics (SWTX), Iterum Therapeutics (ITRM), IMAC Hldgs (BACK), Biodexa Pharmaceuticals (BDRX), Gracell Biotechnologies (GRCL), and Autolus Therapeutics (AUTL).

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 5:31 pm

AIRE

AIXI

ALAR

BELFA

BTDR

BTOG

CLSK

HOLO

HTCR

IREN

MLGO

SOBR

During Tuesday's intraday session, several information technology stocks experienced significant movements. Bit Origin (BTOG), Iris Energy (IREN), Bitdeer Technologies (BTDR), Sobr Safe (SOBR), XIAO-I (AIXI), and Cleanspark (CLSK) were among the gainers, with increases ranging from 13.17% to 16.3%. On the losing side, MicroAlgo (MLGO), Bel Fuse (BELFA), MicroCloud Hologram (HOLO), ReAlpha Tech Corp (AIRE), Alarum Technologies (ALAR), and HeartCore Enterprises (HTCR) saw their stock prices decline between 10.73% and 23.3%. Notably, Alarum Technologies released their Q3 earnings report.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 5:30 pm

ALLK

JMP Securities analyst Jonathan Wolleben has reiterated a 'Market Outperform' rating on Allakos (NASDAQ:ALLK) and maintained a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:26 pm

AFRM

Affirm Holdings Inc.'s stock (AFRM) is trading higher following an upgrade by Jefferies from 'Underperform' to 'Hold'. Additionally, Jefferies increased its price target for Affirm from $9.5 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:24 pm

DELL

MSFT

NVDA

Micron Technology Inc. (MU) raised its revenue and earnings guidance for Q1 2024, signaling a potential end to the chip slump. However, shares dropped due to projected operating expenses of $990 million, exceeding analyst expectations. Dell Technologies Inc. (DELL) secured a $150 million deal with AI startup Imbue, which recently raised funds with Nvidia Corporation's (NVDA) involvement. Dell is also collaborating with Microsoft Corporation (MSFT) to implement Microsoft 365 Copilot, leveraging Dell's technology expertise.

Portfolio Pulse from Upwallstreet

November 28, 2023 | 5:22 pm

AVGO

GOOG

GOOGL

BofA analyst Vivek Arya reaffirmed a Buy rating on Broadcom Inc (AVGO) with a price target of $1200, citing generative AI and custom silicon as key growth drivers. Arya estimates a 2.3% to 7.3% EPS accretion in FY24 and FY25, with potential for over 10% accretion and $60+ EPS in CY25 if synergies are realized quickly. Risks include macro conditions and integrating VMware Inc synergies, as well as managing Broadcom's $67 billion debt. Arya sees any volatility upon VMware's acquisition close as a buying opportunity. Susquehanna analyst Christopher Rolland also maintained a Positive rating on Broadcom, raising the price target from $1010 to $1100. AVGO shares were down slightly at $947.61.

Portfolio Pulse from Anusuya Lahiri

November 28, 2023 | 5:20 pm